Results 151 to 160 of about 10,848 (199)

Chronic Lymphocytic Leukemia: Molecular Pathologies and Therapeutic Strategies. [PDF]

Int J Mol Sci
Meza K, Barrientos Risso C, Shah A, Romagnoli C, Sandoval J, Brauchle Y, Lyubimova A, Santos L, Goya Balaguer E, Barrientos J.   +9 more
europepmc   +1 more source

Network meta-analysis of triple immunosuppressive therapies and standard of care for induction of remission of active lupus nephritis. [PDF]

Lupus
Contreras G, Mechery V, Kota S, Del Castillo Rix D, Bandes M, Dejman A, Zuo Y, Duque JC, Munoz Mendoza J.   +8 more
europepmc   +1 more source

Type-II-CD20-targeted therapy for CD38 antibody-refractory antibody-mediated rejection after kidney transplantation: a case report. [PDF]

Front Immunol
de Fallois J, Baatz S, Krüger BM, Dilz LM, Boldt A, Beck J, Bornemann-Kolatzki K, Petzold F, Daniel C, Amann K, Kowald J.   +10 more
europepmc   +1 more source

Obinutuzumab, lenalidomide, and venetoclax for the initial treatment of patients with advanced-stage follicular lymphoma: Results of the Phase Ib/II LEVERAGE study. [PDF]

Hemasphere
Cheah CY, Blombery P, Johnston A, Wight J, Lewis KL, Bennett R, Xie J, Vlachos S, Hunter SM, Gonzales J, Binks S, Seymour JF.   +11 more
europepmc   +1 more source

Pneumonitis Associated with Immune Checkpoint Inhibitors and Targeted Anticancer Therapies: A Retrospective Case Series of 12 Patients. [PDF]

Diseases
Toma CL, Oprea ȘF, Dumitrache-Rujinski Ș, Belaconi IN, Jipa-Dună D, Cojocaru C, Cristea AM, Diaconu CC, Zaharia DC.   +8 more
europepmc   +1 more source

Comparison of Venetoclax-Based Treatments for Patients With Relapsed/Refractory Chronic Lymphocytic Leukemia: A Single-Center Real-World Experience. [PDF]

EJHaem
Heyman B, Choi M, Kipps TJ.
europepmc   +1 more source

Immune-mediated acute thrombocytopenia within 30 minutes of first obinutuzumab infusion. [PDF]

Blood Vessel Thromb Hemost
Al-Sayyad J, Lara-Martinez HR.
europepmc   +1 more source

Refined Continuous Risk Index for Accurately Predicting Outcomes of Patients With Chronic Lymphocytic Leukemia After Limited-Duration Therapy. [PDF]

J Clin Oncol
Al-Sawaf O, Zhang C, Esfahani MS, Liu CL, Robrecht S, Tausch E, Schilhabel A, Ritgen M, Schneider C, Peifer M, Fürstenau M, Niemann CU, Kater AP, Seymour JF, Chyla B, Jiang Y, Eichhorst B, Stilgenbauer S, Hallek M, Alizadeh AA, Kurtz DM, Fischer K.   +21 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Obinutuzumab

Reactions Weekly
  +25 more sources